Crohn's the third indication for Skyrizi after psoriasis and psoriatic arthritis, and a key step in AbbVie's aim to grow the drug – already one of its top sellers with sales of almost $3 billion ...

Psoriasis is a notoriously competitive market, where Novartis’ Cosentyx (secukinumab) is fast gaining momentum, but the expectation is that Skyrizi will become a blockbuster several times over ...

ABC delivered the most reach for pharma, thanks to its coverage of the NBA playoffs and world news broadcasts.

RTX carries a strong balance sheet with a BBB+ credit rating from S&P. This is supported by $5.2 billion in cash on hand, and ...

Having exhausted every other treatment, Harlech is taking “the Ferrari of psoriasis medication”, Skyrizi (risankizumab), which she self-administers once or twice a year. “It’s an interleukin blocker ...

Amgen is no exception to this dynamic. Although 2017's Tax Cuts and Jobs Act spurred the company to build a handful of new manufacturing sites within the U.S., it's still heavily reliant on its ...

Elizabeth Bannister is a patient-first marketer whose global campaigns empower individuals with psoriasis to seek better care. Since joining AbbVie in 2018, she has helped lead launches for Skyrizi ...

Its key drugs include Humira for treating rheumatoid arthritis, psoriasis, Crohn's disease and other conditions, along with Skyrizi for treating plaque psoriasis, psoriatic arthritis, Crohn's ...

Novo Nordisk slashed its spending on TV ads for Wegovy by almost 24% between April and May, from $31.6 million to $24.1 ...